K. Sreter (Zagreb, Croatia), R. Lee (Beaconsfield, Buckinghamshire, United Kingdom)
Impact of Covid-19 pandemic on care pathways of lung cancer in Longjumeau hospital
A. BAKEBE (Longjumeau, France), J. Petel (Longjumeau, France), M. Awad (Longjumeau, France), G. Oliviero (Longjumeau, France), L. Decoux (Longjumeau, France)
|   |
Lung cancer associated to idiopathic pulmonary fibrosis: predictor ranking and mining.
S. Lettieri (Pavia, Italy), M. Coretti (Pavia, Italy), F. Mariani (Pavia, Italy), C. Bortolotto (Pavia, Italy), F. Agustoni (Pavia, Italy), A. Lancia (Pavia, Italy), P. Rinaldi (Pavia, Italy), C. Primiceri (Pavia, Italy), D. Piloni (Pavia, Italy), L. Saracino (Pavia, Italy), G. Stella (Pavia (PV), Italy)
| |
Prognostic factors in locally advanced non-small cell lung cancer
Y. Hadidene (Ariana, Tunisia), H. Kamoun (Ariana, Tunisia), H. Rejeb (Ariana, Tunisia), D. Greb (Ariana, Tunisia), I. Akrout (Ariana, Tunisia), L. Fkih (Ariana, Tunisia), H. Smadhi (Ariana, Tunisia), M. Megdiche (Ariana, Tunisia)
| |
The association of anxiety and depression with mortality in lung cancer
Y. Aloulou (Tunis, Tunisia), H. Rejeb (Tunis, Tunisia), H. Kammoun (Tunis, Tunisia), D. Greb (Tunis, Tunisia), I. Akrout (Tunis, Tunisia), H. Ben Abdelghaffar (Tunis, Tunisia), H. Hassen (Tunis, Tunisia), L. Fekih (Tunis, Tunisia), H. Smadhi (Tunis, Tunisia), M. Megdich (Tunis, Tunisia)
| |
Impact of cancer cachexia on the course of chemotherapy in patients with advanced lung cancer.
N. Khézami (Tunisia, Tunisia), I. Bachouch (Tunisia, Tunisia), K. Bouguerra (Tunisia, Tunisia), H. Mrassi (Tunisia, Tunisia), A. Zargouni (Tunisia, Tunisia), N. Belloumi (Tunisia, Tunisia), C. Habouria (Tunisia, Tunisia), F. Chermiti (Tunisia, Tunisia), S. Fenniche (Tunisia, Tunisia)
| |
Survival and prognostic factors in NSCLC patients with malignant pleural effusion
A. Navasakulpong (Hatyai (Songkhla), Thailand), P. Kaenmuang (Hatyai (Songkhla), Thailand)
| |
Immunotherapy in metastatic non-small cell lung cancer: EPSILoN as a prognostic score
M. Alves Valente (Porto, Portugal), M. Serino (Porto, Portugal), C. Freitas (Porto, Portugal), M. Martins (Porto, Portugal), P. Ferreira (Porto, Portugal), C. Cardoso (Porto, Portugal), C. Sousa (Porto, Portugal), V. Santos (Porto, Portugal), D. Araújo (Porto, Portugal), H. Novais-Bastos (Porto, Portugal), A. Magalhães (Porto, Portugal), H. Queiroga (Porto, Portugal), G. Fernandes (Porto, Portugal), V. Hespanhol (Porto, Portugal)
| |
Oncological emergencies in lung cancer patients during 2019 and SARS-CoV-2 pandemic year
M. Carvalho Silva (Braga, Portugal), J. Naia (Braga, Portugal), D. Rodrigues (Braga, Portugal), D. Pimenta (Braga, Portugal), S. Campos Silva (Braga, Portugal), J. Pereira (Braga, Portugal), E. Padrão (Braga, Portugal), L. Ferreira (Braga, Portugal)
| |
Pericardial effusion and lung cancer: experience from a UK North East District General hospital
H. Shah (Newcastle, United Kingdom), T. Hannan (Newcastle, United Kingdom), K. Jackson (Newcastle, United Kingdom), P. Jones (Newcastle, United Kingdom), A. Aujayeb (Newcastle, United Kingdom)
| |
Complications of lung cancer in the clinical course of interstitial lung disease
Y. Noguchi (Seto, Japan), R. Takei (Seto, Japan), S. Hayai (Nagoya, Japan), H. Oi (Kashiwa, Japan), Y. Yamano (Seto, Japan), T. Yokoyama (Seto, Japan), T. Matsuda (Seto, Japan), K. Kataoka (Seto, Japan), T. Kimura (Seto, Japan), Y. Kondoh (Seto, Japan)
| |
A new tissue-mimicking surrogate for pulmonary lesions using for RFA
L. Bühler (Tübingen, Germany), S. Schulze (Tübingen, Germany), M. Polke (Heidelberg, Germany), N. Kahn (Heidelberg, Germany), M. Schneider (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), F. Herth (Heidelberg, Germany), M. Enderle (Tübingen, Germany), W. Linzenbold (Tübingen, Germany)
| |
Brown adipose tissue activity predicts cachexia and survival in patients with lung cancer.
L. Hofmann (Leipzig, Germany), J. Meyer (Leipzig, Germany), J. Pappisch (Leipzig, Germany), T. Kerkhoff (Leipzig, Germany), N. Linder (Leipzig, Germany), H. Busse (Leipzig, Germany), S. Hesse (Leipzig, Germany), K. Steinhoff (Leipzig, Germany), T. Ebert (Leipzig, Germany), A. Tönjes (Leipzig, Germany), S. Krämer (Leipzig, Germany), J. Broschewitz (Bremen, Germany), A. Gläser (Leipzig, Germany), S. Taubenheim (Leipzig, Germany), H. Kuhn (Leipzig, Germany), O. Sabri (Leipzig, Germany), H. Wirtz (Leipzig, Germany), A. Frille (Leipzig, Germany)
| |
A single centre analysis of stage of presentation of Lung Cancer pre and post Covid-19 pandemic
C. Ottewill (Dublin 4, Ireland), F. Mulvany (Dublin 4, Ireland), F. O'Connell (Dublin 4, Ireland), P. Nadarajan (Dublin 4, Ireland)
| |
Impact of the covid-19 pandemic on lung cancer referral and treatment
J. Mcadam (Shropshire, United Kingdom), H. Moudgil (Shropshire, United Kingdom), J. Nixon (Shropshire, United Kingdom), K. Srinivasan (Shropshire, United Kingdom), P. Wareing (Shropshire, United Kingdom), E. Crawford (Shropshire, United Kingdom)
| |
Recurrence at site of lung cancer biopsy: experience from a UK district general hospital
A. Aujayeb (Newcastle, United Kingdom)
| |
Impact of the COVID-19 pandemic on suspected lung cancer referrals and subsequent lung cancer diagnosis at North Bristol NHS Trust
A. Ramos Pereira (Bristol (Avon), United Kingdom), C. Coombs (Bristol (Avon), United Kingdom), B. Masterman (Yeovil, United Kingdom), A. Jeyabalan (Bristol (Avon), United Kingdom), M. Plummeridge (Bristol (Avon), United Kingdom), A. Bibby (Bristol (Avon), United Kingdom)
| |